N
PRCT icon

Numerai’s Procept Biorobotics PRCT Stock Holding History

Numerai’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-23,845
Closed -$1.92M – 574
2024
Q4 		$1.92M Sell
23,845
-32,921
-58% -$2.81M 0.53% 50
2024
Q3 		$4.55M Sell
56,766
-2,683
-5% -$191K 1.21% 6
2024
Q2 		$3.63M Buy
59,449
+6,807
+13% +$405K 1.32% 6
2024
Q1 		$2.6M Buy
52,642
+47,194
+866% +$2.25M 1.12% 18
2023
Q4 		$228K Buy
+5,448
New +$186K 0.08% 212

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Numerai's PRCT Position: Q1 2025 in Review

Numerai sold out of Procept Biorobotics (PRCT) in Q1 2025, closing a stake of 23,845 shares — an estimated $1.92M sold.

Numerai first reported a position in PRCT in Q4 2023 and held it in 5 quarters. The position peaked at $4.55M in Q3 2024. 279 funds tracked by Wall St. Rank hold PRCT as of Q1 2025.

  • Numerai reported no remaining Procept Biorobotics position as of Q1 2025 after selling out during the quarter.
  • Numerai sold 23,845 Procept Biorobotics shares in Q1 2025, an estimated $1.92M.
  • Numerai first reported a position in Procept Biorobotics in Q4 2023 and held it in 5 quarters.
  • Numerai's Procept Biorobotics position peaked at $4.55M in Q3 2024.
  • 279 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2025.

Based on Numerai's 13F filing for Q1 2025, filed 15 May 2025.